ALLYSON DUPRE: Open Payments
NPI 1407475031 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,681 in 74 payments from 30 companies in 2025. Trend: 2023 $2,096 · 2024 $1,850 · 2025 $1,681
Food & beverage: $1,681
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $219 |
| Daiichi Sankyo Inc. | 10 | $215 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 5 | $123 |
| AstraZeneca Pharmaceuticals LP | 4 | $89 |
| Lilly USA, LLC | 3 | $69 |
| PFIZER INC. | 3 | $66 |
| Celgene Corporation | 4 | $66 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| BeOne Medicines USA, Inc. | 3 | $56 |
Products named: Enhertu, Fabhalta, ZENPEP, VERZENIO, KISQALI, BRUKINSA, TALVEY, DATROWAY.
Industry payments across LA — which companies pay providers there.
